GSK (GSK) plans to depart the biotechnology industry’s largest trade group, the Biotechnology Innovation Organization, STAT’s John Wilkerson, Lizzy Lawrence, Rachel Cohrs Zhang, and Sarah Owermohle reported on Friday. GSK is the fifth company to leave BIO in roughly a year, a group that includes Pfizer (PFE). The departures coincided with a drop in lobbying spending from the group and other challenges, STAT says.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GSK:
- Ex-Dividend Date Nearing for These 10 Stocks – Week of November 11, 2024
- GSK price target lowered to 1,450 GBp from 1,550 GBp at Barclays
- GSK Pharma put volume heavy and directionally bearish
- GlaxoSmithKline (GSK) Announces Q1 Dividend: Save the Dates!
- GlaxoSmithKline Updates Share Capital and Voting Rights